Christopher Bowden
Director/Miembro de la Junta en Cedilla Therapeutics, Inc. .
Cargos activos de Christopher Bowden
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Cedilla Therapeutics, Inc.
Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | Director/Miembro de la Junta | 21/04/2021 | - |
Historial de carrera de Christopher Bowden
Antiguos cargos conocidos de Christopher Bowden.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ALAUNOS THERAPEUTICS, INC. | Director/Miembro de la Junta | 08/10/2019 | 30/03/2023 |
Independent Dir/Board Member | 08/10/2019 | 30/03/2023 | |
AGIOS PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 14/05/2014 | 01/09/2021 |
VIRIDIAN THERAPEUTICS, INC. | Director/Miembro de la Junta | 10/08/2017 | 01/10/2020 |
Independent Dir/Board Member | 10/08/2017 | 01/10/2020 | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/01/2006 | 01/05/2014 |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01/01/2006 | 01/01/2014 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2003 | 01/01/2006 |
Formación de Christopher Bowden.
Drexel University College of Medicine | Doctorate Degree |
Lake Forest College | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 9 |
Suiza | 2 |
Operativa
Corporate Officer/Principal | 3 |
Director/Board Member | 3 |
Independent Dir/Board Member | 2 |
Sectorial
Health Technology | 7 |
Consumer Services | 3 |
Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 4 |
---|---|
AGIOS PHARMACEUTICALS, INC. | Health Technology |
VIRIDIAN THERAPEUTICS, INC. | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
ALAUNOS THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 3 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Finance |
Cedilla Therapeutics, Inc.
Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Christopher Bowden
- Experiencia